```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 182 Introduced in House (IH)]

110th CONGRESS
  1st Session
H. CON. RES. 182

 Recognizing the need to pursue research into the causes, a treatment, 
and an eventual cure for idiopathic pulmonary fibrosis, supporting the 
 goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness 
                     Week, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 12, 2007

Mr. Deal of Georgia (for himself, Mr. Baird, Mr. Castle, Mr. Upton, Mr. 
Westmoreland, Mr. Gingrey, and Mr. Miller of North Carolina) submitted 
    the following concurrent resolution; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                         CONCURRENT RESOLUTION

 
 Recognizing the need to pursue research into the causes, a treatment, 
and an eventual cure for idiopathic pulmonary fibrosis, supporting the 
 goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness 
                     Week, and for other purposes.

Whereas idiopathic pulmonary fibrosis is a serious lung disorder causing 
        progressive, incurable lung scarring;
Whereas idiopathic pulmonary fibrosis is one of about 200 disorders called 
        interstitial lung diseases;
Whereas idiopathic pulmonary fibrosis is the most common form of interstitial 
        lung disease;
Whereas idiopathic pulmonary fibrosis is a debilitating and generally fatal 
        disease marked by progressive scarring of the lungs, causing an 
        irreversible loss of the lung tissue's ability to transport oxygen;
Whereas idiopathic pulmonary fibrosis progresses quickly, often causing 
        disability or death within a few short years;
Whereas there is no proven cause of idiopathic pulmonary fibrosis;
Whereas more than 128,000 United States citizens have idiopathic pulmonary 
        fibrosis, and more than 48,000 new cases are diagnosed each year 
        representing a 156-percent increase in mortality since 2001;
Whereas idiopathic pulmonary fibrosis is often misdiagnosed or under diagnosed;
Whereas the median survival rate for idiopathic pulmonary fibrosis patients is 2 
        to 3 years; about two-thirds of idiopathic pulmonary fibrosis patients 
        die within 5 years; and approximately 40,000 patients die each year; and
Whereas a need has been identified to increase awareness and detection of this 
        misdiagnosed and under diagnosed disorder as well as all incarnations of 
        pulmonary fibrosis: Now, therefore, be it
    Resolved by the House of Representatives (the Senate concurring),  
That the Congress--
            (1) recognizes the need to pursue research into the causes, 
        a treatment, and an eventual cure for idiopathic pulmonary 
        fibrosis;
            (2) supports the work of advocates and organizations in 
        educating, supporting, and providing hope for individuals who 
        suffer from idiopathic pulmonary fibrosis, including efforts to 
        organize a National Idiopathic Pulmonary Fibrosis Awareness 
        Week;
            (3) supports the designation of an appropriate week as 
        National Idiopathic Pulmonary Fibrosis Awareness Week;
            (4) welcomes the issuance of a proclamation designating a 
        National Idiopathic Pulmonary Fibrosis Awareness Week;
            (5) congratulates advocates and organizations for their 
        efforts to educate the public about idiopathic pulmonary 
        fibrosis, while funding research to help find a cure for this 
        disorder; and
            (6) supports the goals and ideals of National Idiopathic 
        Pulmonary Fibrosis Awareness Week.
                                 <all>
```